Results 271 to 280 of about 2,298,895 (410)

SP774OUTCOME OF PEDIATRIC ABO-INCOMPATIBLE LIVING KIDNEY TRANSPLANTATION BETWEEN 2002 AND 2014: AN ANALYSIS OF THE JAPANESE KIDNEY TRANSPLANT REGISTRY [PDF]

, 2017
Motoshi Hattori, Makiko Mieno, Atushi Aikawa, Shinichi Ohsima, Seiichiro Shishido, Kota Takahashi, Akira Hasegawa, Norio Yoshimura, ion on behalf of the Japanese Society for Transplantat   +8 more
openalex   +1 more source

Six Decades of Organ Donation and the Challenges That Shifting the United States to a Market System Would Create Around the World [PDF]

, 2014
Capron, Alexander M.
core   +1 more source

HSP70 Interactome‐Mediated Proteolysis Targeting Chimera (HSP70‐PROTAC) for Ferroptosis‐Driven Cancer Treatment

Advanced Science, EarlyView.
This study reports a novel targeted protein degradation strategy termed “HSP70‐PROTAC” that recruits Hsc70 complex to a target protein for inducing degradation. Among them, GDAz‐3 exhibits effective GPX4 degradation activity via UPS/CMA processes, triggering ferroptosis‐driven anticancer activity in vitro and in vivo.
Jinyun Dong, Yulong Li, Hui Liang, Zumei Wu, Shiqun Wang, Yichao Wang, Jieyu Xu, Yanning Lan, Maohua Cai, Guangzhao Pan, Haiyan Yang, Kai Miao, Zhe‐Sheng Chen, Fangfang Tao, Xuelei Ma, Jiang‐Jiang Qin   +15 more
wiley   +1 more source

Characterizing the Experiences and Educational Needs of Patients and Caregivers During the Kidney Transplant Process. [PDF]

Can J Kidney Health Dis
Ruhl M, Burghall A, Groot B, Rosaasen N, Flood K, Davis K, Minakakis N, Wichart J, Mansell H.   +8 more
europepmc   +1 more source

Combined Photothermal and mTOR‐Targeted Therapy Overcomes Immune Evasion and Enhances Checkpoint Blockade Efficacy in Metastatic Triple‐Negative Breast Cancer

Advanced Science, EarlyView.
This study reveals that photothermal therapy, while inducing immunogenic cell death in triple‐negative breast cancer, paradoxically activates the oncogenic mTOR pathway to drive immune evasion. To counter this, a smart nanocomposite is engineered to co‐deliver localized hyperthermia and mTOR inhibition.
Yujie Zhao, Jing Yu, Xin Wang, Xu Liu, Fengli Zuo, Tianyue Xu, Leyi Tang, Ling Xiong, Li Li, Huifang Li, Xiaoting Chen, Guang Yang, Jing Jing, Xiaowei Liu   +13 more
wiley   +1 more source

Treatment of Refractory Lymphocele by Lymphangiography in Kidney Transplant. [PDF]

Chonnam Med J
Lee SJ, Yeom J, Hwang HP, Yu HC, Kim KY, Lee S.   +5 more
europepmc   +1 more source

Trigonelline Improves Metabolism and Cardiac Function of HFpEF Mice Via Gut Microbiome Alterations‐Mediated AMPK Activation

Advanced Science, EarlyView.
Metabolomics analyses reveal that trigonelline is markedly reduced in HFpEF hearts. Trigonelline supplementation alleviates metabolic disorders and improves cardiac function in HFpEF mice via gut microbiota‐mediated AMPK activation. Abstract Heart failure with preserved ejection fraction (HFpEF) is a prevalent end‐manifestation of cardiovascular ...
Zhe Cheng, Xiaowen Wang, Jiang Yu, Xiaorong Li, Qing Tang, Can Qu, Ding Yang, Yuanjing Li, Yong Xia, Yongzheng Guo   +9 more
wiley   +1 more source

WCN25-967 REGULAR USE OF TACROLIMUS GENOTYPE TEST AND USE OF FLUCONAZOLE IN FAST METABOLIZERS TO ACHIVE THERAPEUTIC DRUG LEVELS POST KIDNET TRANSPLANTATION

Kidney International Reports
smriti sinha, Sudheer Pandey, Shriram Kabra, Vivek Bansal   +3 more
doaj   +1 more source

PCSK9 inhibitors: a promising lipid-lowering strategy for kidney transplant recipients. [PDF]

Ren Fail
Luo B, Guo L, Di W.
europepmc   +1 more source

Kidney After Nonrenal Transplantation—The Impact of Alemtuzumab Induction

, 2009
Ron Shapiro, Amit Basu, Henkie P. Tan, Claire Morgan, Vivek Sharma, Deanna Blisard, Parmjeet Randhawa, Igor Dvorchik, Jerry McCauley, Demetrius Ellis, J. Wallis Marsh, Steven A. Webber, Geoffrey Kurland, Kenneth R. McCurry, Kareem Abu‐Elmagd, George Mazariegos, Thomas E. Starzl   +16 more
openalex   +2 more sources